As of Mar 23
| -0.80 / -5.08%|
The 6 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 26.50, with a high estimate of 36.00 and a low estimate of 21.50. The median estimate represents a +77.26% increase from the last price of 14.95.
The current consensus among 6 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.